These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19759564)

  • 1. The impact of antigen expression in antigen-presenting cells on humoral immune responses against the transgene product.
    Feng Y; Jacobs F; Van Craeyveld E; Lievens J; Snoeys J; Van Linthout S; De Geest B
    Gene Ther; 2010 Feb; 17(2):288-93. PubMed ID: 19759564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained expression of human apo A-I following adenoviral gene transfer in mice.
    De Geest B; Van Linthout S; Collen D
    Gene Ther; 2001 Jan; 8(2):121-7. PubMed ID: 11313781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Van Linthout S; Lusky M; Collen D; De Geest B
    Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of hepatocyte-specific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer.
    Jacobs F; Snoeys J; Feng Y; Van Craeyveld E; Lievens J; Armentano D; Cheng SH; De Geest B
    Gene Ther; 2008 Apr; 15(8):594-603. PubMed ID: 18288213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells.
    De Geest BR; Van Linthout SA; Collen D
    Blood; 2003 Apr; 101(7):2551-6. PubMed ID: 12446451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle stem cells can act as antigen-presenting cells: implication for gene therapy.
    Cao B; Bruder J; Kovesdi I; Huard J
    Gene Ther; 2004 Sep; 11(17):1321-30. PubMed ID: 15175641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
    Sung RS; Qin L; Bromberg JS
    Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
    Kuzmin AI; Galenko O; Eisensmith RC
    Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
    Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
    Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient siRNA-mediated attenuation of liver expression from an alpha-galactosidase A plasmid reduces subsequent humoral immune responses to the transgene product in mice.
    Chu Q; Joseph M; Przybylska M; Yew NS; Scheule RK
    Mol Ther; 2005 Aug; 12(2):264-73. PubMed ID: 15946902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression.
    Michou AI; Santoro L; Christ M; Julliard V; Pavirani A; Mehtali M
    Gene Ther; 1997 May; 4(5):473-82. PubMed ID: 9274725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of promoters and enhancers on expression, transgene DNA persistence, and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-I.
    Van Linthout S; Collen D; De Geest B
    Hum Gene Ther; 2002 May; 13(7):829-40. PubMed ID: 11975849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid emulsions potently increase transgene expression in hepatocytes after adenoviral transfer.
    Snoeys J; Mertens G; Lievens J; van Berkel T; Collen D; Biessen EA; De Geest B
    Mol Ther; 2006 Jan; 13(1):98-107. PubMed ID: 16112619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
    Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
    J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
    Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
    Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion.
    Schagen FH; Ossevoort M; Toes RE; Hoeben RC
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):51-70. PubMed ID: 15094159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
    Chen P; Tian J; Kovesdi I; Bruder JT
    J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters.
    Weeratna RD; Wu T; Efler SM; Zhang L; Davis HL
    Gene Ther; 2001 Dec; 8(24):1872-8. PubMed ID: 11821941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression.
    Vassalli G; Agah R; Qiao R; Aguilar C; Dichek DA
    Circ Res; 1999 Oct; 85(9):e25-32. PubMed ID: 10532959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.